Inventor profile of:

Oliver POHL

City:

Plan-les-Ouates

Country:

Switzerland

Published Applications:

14

Last publication date:

2024-01-04

Top Assignees for applications by Oliver POHL

The entities that hold a legal rights for patent applications filed by inventor POHL Oliver:

Recent patent applications by POHL Oliver

Oliver POHL from Plan-les-Ouates, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-01-04
US20240000785A1
Human necessities

GONADOTROPIN-RELEASING HORMONE ANTAGONIST DOSING REGIMENS FOR TREATING UTERINE FIBROIDS AND REDUCING MENSTRUAL BLOOD LOSS

#2 | 2023-11-23
US20230372306A1
Human necessities

COMPOSITIONS AND METHODS FOR DELAYING THE INCIDENCE OF LABOR

#3 | 2023-10-12
US20230321052A1
Human necessities

ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF

#4 | 2023-07-20
US20230226021A1
Human necessities

ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES

#5 | 2023-03-30
US20230102503A1
Chemistry; metallurgy

BIOMARKERS FOR OXYTOCIN RECEPTOR ANTAGONIST THERAPY

#6 | 2023-03-02
US20230067378A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISORDERS

#7 | 2022-12-27
US16411974
Human necessities

Compositions and methods for delaying the incidence of labor

#8 | 2022-10-13
US20220323410A1
Human necessities

OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO IMPLANTATION AND PREVENTING MISCARRIAGE

#9 | 2020-09-10
US20200281892A1
Human necessities

Oral formulations of pyrrolidine derivatives

#10 | 2020-06-11
US20200179390A1
Human necessities

Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss

#11 | 2020-05-21
US20200155515A1
Human necessities

Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof

#12 | 2019-01-03
US20190000812A1
Human necessities

Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof

#13 | 2018-11-01
US20180311211A1
Human necessities

Oral formulations of pyrrolidine derivatives

#14 | 2015-06-18
US20150164859A1
Human necessities

Oral formulations of pyrrolidine derivatives

InventorID:

1193088 ⎘